Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 1/2 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Squamous Cell Carcinoma of Head and Neck 11Nasopharyngeal Carcinoma 6Oropharyngeal Neoplasms 5Prostatic Neoplasms 4Laryngeal Neoplasms 4Carcinoma 4Mouth Neoplasms 3Hypopharyngeal Neoplasms 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Mesothelioma 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Anus Neoplasms 2Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Oligodendroglioma 1Mesothelioma, Malignant 1Meningioma 1Lymphoma, Follicular 1Lymphoid Interstitial Pneumonia 1Locally Advanced Cervical Adenocarcinoma 1HIV Infections 1Glioma 1Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 28enzalutamide 23Specimen Handling 20apalutamide 17Androgen Antagonists 14Radiosurgery 13Radiotherapy 12Prednisone 12Docetaxel 12Abiraterone Acetate 12abiraterone 10Biopsy 10Radiation 8niraparib 6luprolide acetate gel depot 6darolutamide 6Pluvicto 6Leuprolide 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6relugolix 5gallium 68 PSMA-11 5cabazitaxel 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Nivolumab 5Gonadotropin-Releasing Hormone 5bicalutamide 4Triptorelin Pamoate 4Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Glutamate Carboxypeptidase II 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT02177292 2026-05-26

SIB

Medical College of Wisconsin

Phase NA Active not recruiting
80 enrolled
Genitourinary

Prostatic Neoplasms

NCT04037254 2026-05-20

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

NRG Oncology

Phase 1/2 Completed
22 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT04423211 2026-05-15

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Eastern Cooperative Oncology Group

Phase 3 Recruiting
804 enrolled
Genitourinary

Prostatic Neoplasms

NCT01368588 2026-05-08

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Radiation Therapy Oncology Group

Phase 3 Active not recruiting
2,590 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡